Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Blood Cell Count × Thoracic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Lymphoid 3 Thoracic 1 Plasma cell 1

Conditions

Lung Neoplasms 1

Interventions

Blood Specimen Collection 33 Surveys and Questionnaires 23 Surgical Procedures, Operative 19 Carboplatin 19 Immunotherapy 16 Drug Therapy 16 pembrolizumab 15 osimertinib 15 Radiotherapy 15 Nivolumab 15 Immune Checkpoint Inhibitors 15 atezolizumab 13 Cisplatin 13 Specimen Handling 12 Observation 12 Gene Expression Profiling 12 Bevacizumab 12 Afatinib 12 Pemetrexed 11 Magnetic Resonance Spectroscopy 11 lorlatinib 10 Immunohistochemistry 10 Biopsy 10 Paclitaxel 9 Erlotinib Hydrochloride 9 alectinib 8 Crizotinib 8 durvalumab 7 Therapeutics 7 Polymerase Chain Reaction 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03749512 2018-11-21

NLCR in Prediction of the Grade of Lung Tumor.

Medical University of Silesia

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡